Global Genome Editing Market Growth (Status and Outlook) 2023-2029

Global Genome Editing Market Growth (Status and Outlook) 2023-2029

Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations.

LPI (LP Information)' newest research report, the “Genome Editing Industry Forecast” looks at past sales and reviews total world Genome Editing sales in 2022, providing a comprehensive analysis by region and market sector of projected Genome Editing sales for 2023 through 2029. With Genome Editing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genome Editing industry.

This Insight Report provides a comprehensive analysis of the global Genome Editing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genome Editing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genome Editing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genome Editing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genome Editing.

The global Genome Editing market size is projected to grow from US$ 3436.6 million in 2022 to US$ 6548.3 million in 2029; it is expected to grow at a CAGR of 9.6% from 2023 to 2029.

The increasing application of genome engineering in treating chronic ailments and therapeutics will be one of the key factors fueling the growth of genome editing market during the next few years. With the continuous prevalence of infectious and chronic diseases such as hepatitis, tuberculosis, malaria, HIV/AIDS, and others, the application of genome editing in treating these ailments has increased considerably in the recent years. According to CDC, there were about 1.8 million new cases of HIV reported in 2016. Such a rapidly increasing number of HIV cases have led to the researchers to work on new gene-based therapies for reducing morbidity and mortality of HIV-infected patients. Consequently, the rise in prevalence of such ailments will impact the demand for novel therapies equipping several genome editing tools in the forthcoming years.

This report presents a comprehensive overview, market shares, and growth opportunities of Genome Editing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
CRISPR
TALEN
ZFN

Segmentation by application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genscript
Horizon Discovery Group
Lonza
Merck KGaA
Sangamo Therapeutics
Thermo Fisher Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.